930
Chapter 33
34. Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature
review.
Breast Cancer Res Treat
2008;108:333–338.
35. Kuerer HM, CunninghamJD, Bleiweiss IJ, et al. Conservative surgery for
breast carcinoma associated with pregnancy.
Breast J
1999;4:171–176.
36. Gentilini O, Gremonesi M, Trifiro G, et al. Safety of sentinel
node biopsy in pregnant patients with breast cancer.
Ann Oncol
2004;15:1348–1351.
37. Keleher A, Wendt R III, Delpassand E, et al. The safety of lymphatic
mapping in pregnant breast cancer patients using Tc-99 m sulfur col
loid.
Breast J
2004;10:492–495.
38. Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node bi
opsy during pregnancy: initial clinical experience.
Ann Surg Oncol
2007;14:218–221.
39. Khera SY, Kiluk JV, Hasson DM, et al. Pregnancy-associated breast
cancer patients can safely undergo lymphatic mapping.
Breast J
2008;14:25–254.
40. Pruthi S, Haakenson C, Brost BC, et al. Pharmacokinetics of methy
lene blue dye for lymphatic mapping in breast cancer-implications for
use in pregnancy.
Am J Surg
2011;201:70–75.
41. Spanheimer PM, Graham MM, Sugg SL, et al. Measurement of uter
ine radiation exposure from lymphoscintigraphy indicates safety
of sentinel lymph node biopsy during pregnancy.
Ann Surg Oncol
2009;16:1143–1147.
42. Anderson BO, Petre JA, Byrd DR, et al. Pregnancy influences breast
cancer stage at diagnosis in women 30 years of age or younger.
Am J
Obstet Gynecol
1996;3:204–211.
43. Nugent P, O’Connell TX. Breast cancer in pregnancy.
Arch Surg
1985;120:1221–1224.
44. Maggard MA, O’Connell JB, Lane KE, et al. Do young breast cancer
patients have worse outcomes?
J Surg Res
2003;113:109–113.
45. Guinee VF, Olsson H, Möller T, et al. Effect of pregnancy on prognosis
for young women with breast cancer.
Lancet
1994;343:1587–1589.
46. Surbone A, Petrek JA. Childbearing issues in breast carcinoma survi
vors.
Cancer
1997;79:1271–1278.
47. Danforth DN. How subsequent pregnancy affects outcome in women
with a prior breast cancer.
Oncology
1991;11:23–29.
48. Petrek JA. Pregnancy safety after breast cancer.
Cancer
1994;74:528–531.
49. Lawrenz B, Banys M, Henes M, et al. Pregnancy after breast cancer:
case report and review of the literature.
Arch Gynecol Obstet
2011;
283:837–843.
50. Velentgas P, Daling JR, Malone KE, et al. Pregnancy after breast carci
noma:outcomesandinfluenceonmortality.
Cancer
1999;85:2424–2432.
51. Salamon MA, Sherer DM, Saller DNJ, et al. Placental metastases
in a patient with recurrent breast carcinoma.
Am J Obstet Gynecol
1994;171:573–574.
52. Eltorky M, Khare VK, Osborne P, et al. Placental metastasis
from maternal carcinoma. A report of three cases.
J Reprod Med
1995;40:399–403.
53. Tan K, Sinclair E, Angus G, et al. Mucinous adenocarcinoma of the
breast metastatic to the placenta.
Pathology
2010;42:688–690.
Carcinoma in Young Adult Women
54. Chung M, Chang HR, Bland KI, et al. Younger women with breast
carcinoma have a poorer prognosis than older women.
Cancer
1996;77:97–103.
55. Simmons PS, Jayasinghe YL, Wold LE, et al. Breast carcinoma in
young women.
Obstet Gynecol
2011;118:529–536.
56. Kothari AS, Beechey-Newman N, D’Arrigo C, et al. Breast carcinoma
in women age 25 years or less.
Cancer
2002;94:606–614.
57. Feldman AL, Welch JP. Long-term outcome in women less than
30 years of age with breast cancer.
J Surg Oncol
1998;68:193–198.
58. Xiong Q, Valero V, Kau V, et al. Female patients with breast carci
noma age 30 years and younger have a poor prognosis. The M.D.
Anderson Cancer Center experience.
Cancer
2001;92:2523–2528.
59. Peng R, Wang S, Shi Y, et al. Patients 35 years old or younger with
operable breast cancer are more at risk for relapse and survival: a ret
rospective matched case-control study.
Breast
2011;20:568–573.
60. Liukkonen S, Leidenius M, Saarto T, et al. Breast cancer in very young
women.
Eur J Surg Oncol
2011;37:1030–1037.
61. Lein BC, Alex WR, Zebley M, et al. Results of needle localized breast
biopsy in women under age 50.
Am J Surg
1996;171:356–359.
7. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated
breast cancer.
Cancer
1991;67:869–872.
8. Ahn BY, Kim HH, Moon WK, et al. Pregnancy-and lactation-
associated breast cancer: mammographic and sonographic findings.
J
Ultrasound Med
2003;22:491–497.
9. Mazonakis M, Varveris H, Damilakis J, et al. Radiation dose to con
ceptus resulting from tangential breast irradiation.
Int J Radiat Oncol
Biol Phys
2003;55:386–391.
10. Swinford AE, Adler DD, Garver KE. Mammographic appearance of
the breasts during pregnancy and lactation: false assumptions.
Acad
Radiol
1998;5:467–472.
11. Liberman L, Geiss CS, Dershaw DD, et al. Imaging of pregnancy-
associated breast cancer.
Radiology
1994;191:245–248.
12. Hogge JP, Shaw de Paredes E, Magnant DM, et al. Imaging and man
agement of breast masses during pregnancy and lactation.
Breast J
1999;5:272–283.
13. Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of
breast disorders related to pregnancy and lactation.
Radiographics
2007;27:S101–S124.
14. Yang WT, Dryden MJ, Gwyn K, et al. Imaging of breast cancer di
agnosed and treated with chemotherapy during pregnancy.
Radiology
2006;239:52–60.
15. Espinosa LA, Daniel BL, Vidarsson L, et al. The lactating breast:
contrast-enhanced MR images of normal tissue and cancer.
Radiology
2005;237:429–436.
16. Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during
pregnancy. International recommendations from an expert meeting.
Cancer
2006;106:237–246.
17. Bottles K, Taylor RN. Diagnosis of breast masses in pregnant and lactat
ing women by aspiration cytology.
Obstet Gynecol
1985;66:76S–78S.
18. Novotny DB, Maygarden SJ, Shermer RW, et al. Fine needle aspiration
of benign and malignant breast masses associated with pregnancy.
Acta Cytol
1991;35:676–686.
19. Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics
and prognosis of breast cancer patients associated with pregnancy
and lactation: analysis of case-control study in Japan.
Jpn J Cancer Res
1992;83:1143–1149.
20. Tobon H, Horowitz LF. Breast cancer during pregnancy.
Breast Dis
1993;6:127–134.
21. King RM, Welch JS, Martin Jr JK, et al. Carcinoma of the breast associ
ated with pregnancy.
Surg Gynecol Obstet
1985;160:228–232.
22. Ribeiro G, Jones DA, Jones M. Carcinoma of the breast associated with
pregnancy.
Br J Surg
1980;73:607–609.
23. Middleton LP, Amin M, Gwyn K, et al. Breast carcinoma in pregnant
women: assessment of clinicopathologic and immunohistochemical
features.
Cancer
2003;98:1055–1060.
24. Reed W, Sandstad B, Holm R, et al. The prognostic impact of hor
mone receptors and c-erbB-2 in pregnancy-associated breast cancer
and their correlation with BRCA1 and the cell cycle.
Int J Surg Pathol
2003;11:65–74.
25. Elledge RM, Ciocca DR, Langone G, et al. Estrogen receptor, proges
terone receptor, and HER-2/neu protein in breast cancers from preg
nant patients.
Cancer
1993;71:2499–2506.
26. Shousha S. Breast carcinoma presenting during or shortly after preg
nancy and lactation.
Arch Pathol Lab Med
2000;124:1053–1060.
27. García-Manero M, Royo MP, Espinos J, et al. Pregnancy associated
breast cancer.
Eur J Surg Oncol
2009;35:215–218.
28. Abellar RG, Pepperell JR, Greco D, et al. Effects of chemotherapy
during pregnancy on the placenta.
Pediatr Dev Pathol
2009;12:35–41.
29. Pavlidis N, Pentheroudakis G. The pregnant mother with breast
cancer: diagnostic and therapeutic management.
Cancer Treat Rev
2005;31:439–447.
30. Aviles A, Neri N. Hematological malignancies and pregnancy: a final
report on 84 children who received chemotherapy in utero.
Clin Lym-
phoma
2001;2:173–177.
31. Gemignani ML, Petrek JA. Pregnancy-associated breast cancer: diag
nosis and treatment.
Breast J
2000;6:68–73.
32. Colfry AJ III. Miscellaneous syndromes and their management: occult
breast cancer, breast cancer in pregnancy, male breast cancer, surgery
in stage IV disease.
Surg Clin North Am
2013;93:519–531.
33. Daniilidis A, Giannoulis C, Sardeli C, et al. Pregnancy-associated breast
cancer—a review analysis.
Eur J Gynaecol Oncol
2010;31:485–490.
